JP2003529593A5 - - Google Patents

Download PDF

Info

Publication number
JP2003529593A5
JP2003529593A5 JP2001572483A JP2001572483A JP2003529593A5 JP 2003529593 A5 JP2003529593 A5 JP 2003529593A5 JP 2001572483 A JP2001572483 A JP 2001572483A JP 2001572483 A JP2001572483 A JP 2001572483A JP 2003529593 A5 JP2003529593 A5 JP 2003529593A5
Authority
JP
Japan
Prior art keywords
hydroxymutilin
ester
carbamic acid
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001572483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003529593A (ja
Filing date
Publication date
Priority claimed from GBGB0008260.2A external-priority patent/GB0008260D0/en
Priority claimed from GB0027182A external-priority patent/GB0027182D0/en
Application filed filed Critical
Priority claimed from PCT/EP2001/003594 external-priority patent/WO2001074788A1/en
Publication of JP2003529593A publication Critical patent/JP2003529593A/ja
Publication of JP2003529593A5 publication Critical patent/JP2003529593A5/ja
Pending legal-status Critical Current

Links

JP2001572483A 2000-04-04 2001-03-29 抗菌剤として用いるための2−ヒドロキシムチリンカルバメート誘導体 Pending JP2003529593A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0008260.2 2000-04-04
GBGB0008260.2A GB0008260D0 (en) 2000-04-04 2000-04-04 Novel compounds
GB0027182.5 2000-11-04
GB0027182A GB0027182D0 (en) 2000-11-04 2000-11-04 Novel comounds
PCT/EP2001/003594 WO2001074788A1 (en) 2000-04-04 2001-03-29 2-hydroxy-mutilin carbamate derivatives for antibacterial use

Publications (2)

Publication Number Publication Date
JP2003529593A JP2003529593A (ja) 2003-10-07
JP2003529593A5 true JP2003529593A5 (enExample) 2008-05-15

Family

ID=26244040

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001572483A Pending JP2003529593A (ja) 2000-04-04 2001-03-29 抗菌剤として用いるための2−ヒドロキシムチリンカルバメート誘導体

Country Status (21)

Country Link
US (1) US6972297B2 (enExample)
EP (1) EP1268443B1 (enExample)
JP (1) JP2003529593A (enExample)
KR (1) KR100758441B1 (enExample)
CN (1) CN1210267C (enExample)
AR (1) AR030203A1 (enExample)
AT (1) ATE437860T1 (enExample)
AU (2) AU6382701A (enExample)
BR (1) BR0109809A (enExample)
CA (1) CA2405132A1 (enExample)
CO (1) CO5280223A1 (enExample)
CZ (1) CZ20023290A3 (enExample)
DE (1) DE60139382D1 (enExample)
ES (1) ES2328109T3 (enExample)
HU (1) HUP0300370A3 (enExample)
IL (1) IL151887A0 (enExample)
MX (1) MXPA02009816A (enExample)
NO (1) NO324229B1 (enExample)
NZ (1) NZ521536A (enExample)
PL (1) PL358666A1 (enExample)
WO (1) WO2001074788A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024811D0 (en) 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
US7176310B1 (en) 2002-04-09 2007-02-13 Ucb Sa Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
DE60317208T2 (de) * 2002-07-24 2008-08-07 Nabriva Therapeutics Forschungs Gmbh Pleuromutilinderivate als antimikrobielle mittel
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
FR2856685B1 (fr) * 2003-06-25 2005-09-23 Merck Sante Sas Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US20090291987A1 (en) * 2004-12-13 2009-11-26 Glaxo Group Limited Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl) carbamic acid 2-(s)-hydroxymutilin 14-ester
CN101120001A (zh) * 2004-12-27 2008-02-06 杏林制药株式会社 12位取代姆替林衍生物
US20080139626A1 (en) * 2005-03-10 2008-06-12 Rittenhouse Stephen F Novel Method
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
KR100695541B1 (ko) * 2005-10-31 2007-03-16 한국단자공업 주식회사 연결터미널
WO2007079173A2 (en) * 2005-12-30 2007-07-12 Emergent Biosolutions Inc. Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
US8222407B2 (en) * 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
EP2014640A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives
JP2010100582A (ja) * 2008-10-24 2010-05-06 Kyorin Pharmaceut Co Ltd 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
EP2253617A1 (de) 2009-05-20 2010-11-24 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
HRP20210010T1 (hr) * 2015-06-17 2021-03-05 Nabriva Therapeutics GmbH Injekcijske farmaceutske formulacije lefamulina
CN113543827B (zh) * 2019-02-27 2025-01-21 奥蒂卡拉股份有限公司 用于治疗鼻、鼻腔鼻窦和鼻咽组织感染和/或炎症的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025309A1 (en) 1996-01-03 1997-07-17 Smithkline Beecham Plc Carbamoyloxy derivatives of mutiline and their use as antibacterials
HUP0001741A3 (en) * 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
FR2771008B1 (fr) 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
GB9817029D0 (en) 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds

Similar Documents

Publication Publication Date Title
JP2003529593A5 (enExample)
EP3409667B1 (en) Amide compounds for the treatment of hiv infections
US10906895B2 (en) Processes for the preparation of benzodiazepine derivatives
CN109790168B (zh) 取代的吡咯嗪化合物及其用途
EP2943481B1 (en) (hetero)arylacetamide derivatives as antiretroviral agents
JP6524081B2 (ja) ジヒドロピリミジン化合物及び医薬におけるその適用
CN102015705B (zh) 稠合的杂环衍生物及其用途
TWI699359B (zh) 4h-吡咯[3,2-c]吡啶-4-酮衍生物
CA2650119C (en) Dihydropyrazolopyrimidinone derivatives
EA021463B1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
AU2014272776A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
GB0004887D0 (en) Chemical compounds
TW202120496A (zh) 作為cd38抑制劑之雜雙環醯胺
CN105121418A (zh) 苯并噻唑-6-基乙酸衍生物及其治疗hiv感染的用途
BR9914379A (pt) Composto, processo para a preparação de um composto, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, e, composição farmacêutica
CN115443276B (zh) 吡啶并嘧啶酮衍生物及其作为芳烃受体调节剂的应用
JP2007517006A5 (enExample)
JP2006515373A5 (enExample)
EP3752506B1 (en) Pyrimidine derivatives for prevention and treatment of bacterial infections
JP2005513020A5 (enExample)
ES2992772T3 (en) Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection
WO2019154329A1 (zh) 具有bet抑制活性的化合物及其制备方法和用途
WO2014020531A1 (en) Imidazo[1,2-b]pyridazin-6-amine derivatives as kinase jak-2 inhibitors
TWI902715B (zh) 作為parp7抑制劑的嗒酮
CN112707873B (zh) 取代的噁唑类衍生物及其在药物中的应用